Dukascopy Bank Launches Separate Stock CFD Platform With 25,000+ Instruments
Dukascopy Bank announced a dedicated Stock Trading Platform offering 25,000+ CFDs on stocks and ETFs, run separately from JForex and accessible through JForex4 Desktop. The bank says the long-only platform uses 1:1 leverage and does not support automated strategies.
Separate environment within JForex4
In an announcement dated June 5, 2026, Dukascopy Bank says the Stock Trading Platform is designed to extend its multi-asset offering beyond JForex without replacing or disrupting existing JForex arrangements. The platform operates as a separate environment and is accessible directly through JForex4 Desktop. The bank states that stocks and ETFs already available on JForex will not appear on the new platform; the 25,000+ figure refers to the CFDs on stocks and ETFs offered there.
Trading terms versus JForex
The announcement compares the Stock Trading Platform with a JForex account. It lists 25,000+ CFDs on stocks and ETFs on the new platform versus 1,500+ stocks/ETFs on JForex; 20 countries/markets, with plans for 87, versus 18; long-only positions versus short and long; and 1:1 leverage versus 1:10. Automated strategies are not supported on the new platform but are supported on JForex. The bank also states no exposure limits for the Stock Trading Platform, while JForex exposure is subject to limitations. These are the company's stated terms.
Funding and setup
Funding for the Stock Trading Platform is only through a JForex sub-account, according to the announcement, and all JForex funding methods are available. The announcement lists wire transfer, payment cards, Skrill, Neteller and crypto among the JForex methods. Setup instructions are to open a Stock CFD sub-account from the Client Cabinet, transfer funds from the JForex account, then open JForex4 Desktop, go to Services, click Stock Trading Platform and start trading.
Article information
This article draws on the cited sources and relevant public material. It may include summaries, translations or supporting analysis and does not replace the full announcement, regulatory document or dataset. Check facts, definitions, statistical methods and effective conditions against the original source, particularly where a translation differs.
Companies, broker brands and legal entities must be distinguished. A licence, permission or announcement concerning one entity should not automatically be applied to related brands, other entities, products or jurisdictions. Reporting and commentary do not constitute investment advice, trading recommendations or assurances of safety, compliance or suitability.
Information is time-sensitive: announcements, register entries and data may be updated or revised. The publication and update dates on this page refer to this website’s article record and may differ from the event or original release date. Before acting, check current source material, the applicable jurisdiction and your actual contracting entity.